Product
Tumor Associated Antigen Peptide Vaccine P30-EPS
1 clinical trial
2 indications
Indication
GliomaIndication
malignantClinical trial
ETAPA I: Evaluation of Tumor Associated P30-Peptide Antigen I; A Pilot Trial of Peptide-based Tumor Associated Antigen Vaccines in Newly Diagnosed, Unmethylated, and Untreated Glioblastoma (GBM)Status: Recruiting, Estimated PCD: 2025-04-01